⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VBIO News
Valion Bio, Inc. Common Stock
Form 8-K/A
sec.gov
VBIO
Form 8-K
sec.gov
VBIO
Ukraine's Ministry Of Health Advances Entolimod Review Into Technical Assessment Phase
accessnewswire.com
VBIO
Valion Bio Announces U.S. Government-Funded Entolimod Studies Targeting Lethal Radiation-Induced GI Injury
accessnewswire.com
VBIO
Form 8-K
sec.gov
VBIO
Ukraine Ministry of Health Accepts Entolimod Dossier for Formal Review Under Regulatory Equivalence Pathway
prnewswire.com
VBIO
World-Premier Cancer Center Sheba Medical Center Selects Entolimod for Clinical Trial, Potentially Expanding Valion Bio into the Multi-Billion-Dollar Neutropenia Market
prnewswire.com
VBIO
Form 8-K
sec.gov
VBIO
Valion Bio Advances Integrated Biodefense and Immunology Platform Through Continued Government Engagement, Domestic Manufacturing and Oncology Expansion
prnewswire.com
VBIO
AFRRI/NIAID Designs Proprietary PBI-BM2.5 Protocol to Evaluate Valion Bio's (NASDAQ: VBIO) Entolimod as the First and Only Treatment for GI-ARS
prnewswire.com
VBIO